-

Rising Pharma Holdings Inc.’s Statement Regarding Recent Articles

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Several recent articles inaccurately state an affiliation between Rising Pharma Holdings, Inc., and Rising Pharmaceuticals, Inc., and its parent company, ACETO Corporation. To be clear, Rising Pharma Holdings, Inc., doing business as Rising Pharmaceuticals, is a separate and distinct entity, and is in no way affiliated or associated with Rising Pharmaceuticals, Inc., or ACETO Corporation.

For some background:

  1. On February 19, 2019, Rising Pharmaceuticals, Inc., a company based in Saddle Brook, New Jersey, filed for bankruptcy protection under chapter 11 of the United States Bankruptcy Code.
  2. During the pendency of Rising Pharmaceutical Inc.’s bankruptcy proceeding, Rising Pharma Holdings, Inc., purchased certain assets related to Rising Pharmaceutical Inc.’s pharmaceutical business.
  3. Rising Pharma Holdings, Inc.’s acquisition of the pharmaceutical assets closed in April 2019.

Prior to its acquisition of certain of Rising Pharmaceuticals Inc.’s assets, Rising Pharma Holdings, Inc., was in no way involved in, or part of, any actions committed by Rising Pharmaceuticals, Inc., or ACETO Corporation.

About Rising Pharma Holdings, Inc.

Rising Pharma Holdings, Inc., a privately held company, sells generic prescription products and over-the-counter pharmaceutical products under the Rising label to leading wholesalers, chain drug stores, distributors and mass merchandisers. At Rising Pharma Holdings, Inc., we continually seek new opportunities to develop our business through strategic partnerships with manufacturers, marketers and distributors under the Rising label.

Contacts

For further information:
Kristina Perez
201-961-9000
CS@RisingPharma.com

Rising Pharma Holdings, Inc.


Release Versions

Contacts

For further information:
Kristina Perez
201-961-9000
CS@RisingPharma.com

More News From Rising Pharma Holdings, Inc.

Rising Pharmaceuticals announces commercial availability of Edetate calcium disodium injection in the United States

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Rising Pharmaceuticals, Inc. announces commercial availability of Edetate calcium disodium injection in the United States...

Rising Pharmaceuticals Launches Edetate Calcium Disodium Injection, an Important Antidote Treatment to Address Lead Poisoning.

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Rising Pharmaceuticals announced the approval, launch and immediate commercial availability of Edetate calcium disodium injection....

Rising Pharmaceuticals and Laurus Labs Partner to Support the University of Minnesota to Explore the Prophylaxis Effect of Hydroxychloroquine in Essential Health Care Workers

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Rising Pharma Holdings Inc., the global pharmaceutical company operating as Rising Pharmaceuticals, today announced its collaborative agreement with the Division of Infectious Disease and International Medicine at the University of Minnesota, Department of Infectious Disease on a clinical trial exploring hydroxychloroquine as preventive treatment for coronavirus disease 2019 (COVID-19). Hydroxychloroquine is a medication used for the prevention and treatme...
Back to Newsroom